CHIRALDEX™ G-TA is one of the top choices for the analysis of Group 1 CSPs (Surface Interactions, Complex Derivatives). It has been shown to be the most broadly-selective phase for the pharmaceutical industry, especially for the analysis of chiral intermediates and drug studies in various stages of clinical trials.